Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data

INTRODUCTION: Nivolumab has been approved in patients with melanoma with lymph node involvement or metastatic disease who have undergone complete resection, in the adjuvant setting. A pivotal trial compared nivolumab with ipilimumab; however, no head-to-head trial exists comparing nivolumab to obser...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Ther
Autors principals: Freeman, Morganna, Betts, Keith A., Jiang, Shan, Du, Ella X., Gupte-Singh, Komal, Lu, Yichen, Rao, Sumati, Shoushtari, Alexander N.
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822822/
https://ncbi.nlm.nih.gov/pubmed/31440980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-01060-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars